Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Journal of Neurochemistry|November 24, 2021
Psychedelic-inspired approaches for treating neurodegenerative disordersHannah N Saeger, David E OlsonJournal of Medicinal Chemistry|April 22, 2024
Psychoplastogenic DYRK1A Inhibitors with Therapeutic Effects Relevant to Alzheimer's DiseaseHunter T Warren, Hannah N Saeger, Robert J Tombari, et al.ACS Chemical Neuroscience|January 11, 2023
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic TryptaminesLindsay P Cameron, Seona D Patel, Maxemiliano V Vargas, et al.ACS Chemical Neuroscience|September 28, 2025
Indolethylamine <i>N</i>-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine ProductionCassandra J Hatzipantelis, Lindsay P Cameron, Min Liu, et al.Biochemistry|January 21, 2022
Biochemical Mechanisms Underlying Psychedelic-Induced NeuroplasticityDavid E OlsonACS Pharmacology & Translational Science|April 16, 2021
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic EffectsDavid E OlsonJournal of Experimental Neuroscience|September 29, 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting NeurotherapeuticsDavid E OlsonNeuroscience Insights|August 5, 2021
Engineering Safer Psychedelics for Treating AddictionJamie Peters, David E OlsonScience (New York, N.Y.)|February 16, 2023
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptorsMaxemiliano V Vargas, Lee E Dunlap, Chunyang Dong, et al.ACS Chemical Neuroscience|July 24, 2018
Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT)Lindsay P Cameron, David E OlsonPageof 8